Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/124030| Title: | HPV vaccination of immunocompromised hosts |
| Author: | Garland, Suzanne M. Brotherton, J. M. L. Moscicki, Anna-Barbara Kaufmann, A. M. Stanley, Margaret Bhatla, N. Sankaranarayanan, Rengaswamy Sanjosé Llongueras, Silvia de Palefsky, Joel |
| Keywords: | Vacuna del papil·lomavirus Papillomavirus vaccines |
| Issue Date: | 1-Dec-2017 |
| Publisher: | Elsevier |
| Abstract: | It is well-established that immunocompromised people are at increased risk of HPV-related disease compared with those who are immunocompetent. Prophylactic HPV sub-unit vaccines are safe and immunogenic in immunocompromised people and it is strongly recommended that vaccination occur according to national guidelines. When delivered to immunocompromised populations, HPV vaccines should be given as a 3-dose regimen. |
| Note: | Reproducció del document publicat a: http://dx.doi.org/10.1016/j.pvr.2017.06.002 |
| It is part of: | Papillomavirus Research, 2017, vol. 4, p. 35-38 |
| URI: | http://hdl.handle.net/2445/124030 |
| Related resource: | http://dx.doi.org/10.1016/j.pvr.2017.06.002 |
| Appears in Collections: | Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| GarlandSM.pdf | 237.86 kB | Adobe PDF | View/Open |
This item is licensed under a
Creative Commons License
